IGF2BP1 and fibrolamellar hepatocellular carcinoma: It is confirmed that the expression of m6A binding protein IGF2BP1 mRNA is increased by 100 times in the study of fibrolamellar hepatocellular carcinoma, while the p53 cancer-suppressing pathway is significantly inactivated in the FL-HCC cells [36–38].